Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

Leaders

Glioblastoma awareness day

Published

on

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) is an oncology-focused drug development company.

Their lead program is paxalisib, which is being developed to treat glioblastoma (GBM), the most common and aggressive form of primary brain cancer in adults. There are few treatment options for sufferers of GBM and around 65% of sufferers do not respond to currently available treatments. The condition affects around 133,000 people globally per annum and the potential addressable market is worth more than US$1 billion.

Kazia’s drug paxalisib, commenced recruitment to GBM AGILE, a pivotal study in glioblastoma, in January 2021. Eight additional studies are active in various forms of brain cancer. Paxalisib was granted Orphan Drug Designation for glioblastoma by the US FDA in February 2018, and Fast Track Designation for glioblastoma by the US FDA in August 2020. Kazia is also developing EVT801, a small-molecule inhibitor of VEGFR3, which was licensed from Evotec SE in April 2021. Preclinical data for EVT801 has shown it to be active against a broad range of tumour types and has provided compelling evidence of synergy with immuno- oncology agents.

A phase I study is expected to begin in CY2021. Competitive Advantages: – Lead program, paxalisib, sourced from the world’s most successful cancer drug developer, Genentech – Experienced team with extensive backgrounds in big pharma and biotech – Around 65% of GBM sufferers do not respond to current treatments – Multiple shots on goal with collaborations progressing in other cancers; largely funded by participating hospitals.

For more information, head to their website.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Leaders

AI and automation reshape future tech careers

AI transformation reshapes tech careers, creating demand for new roles and skills, says Promise Akwaowo from Royal Mail Group

Published

on

AI transformation reshapes tech careers, creating demand for new roles and skills, says Promise Akwaowo from Royal Mail Group

In Short:
– AI is rapidly changing tech careers, creating new roles like AI business analyst and AI engineer.
– ICT professionals need to develop skills in AI, data literacy, and cybersecurity to stay competitive.

Promise Akwaowo, CBAP®, is a business analyst and product owner working across enterprise automation, data governance, and large-scale digital transformation.

In this discussion, Promise highlights how AI and automation are rapidly reshaping tech careers, creating entirely new roles across the global ICT landscape. According to him, AI has become a core requirement in tech hiring, with around 78% of job listings now referencing artificial intelligence.

Roles such as AI business analysts and AI engineers are growing quickly, with seven of the ten fastest-growing tech jobs linked to AI. At the same time, rising concerns around data use, privacy, and trust are driving demand for governance specialists and analysts focused on AI ethics.

Data literacy

To remain competitive, ICT professionals are expected to expand their skill sets, with data literacy, cloud fluency, cybersecurity, and automation projected to be essential by 2026. For businesses, investing in AI-ready talent is key to improving efficiency and supporting long-term growth.

Promise has also worked across sectors, including logistics, higher education, and investor relations technology, focusing on turning complex concepts into scalable digital products. His projects often apply human-centred design principles while emphasising clearly defined performance outcomes.

 


Download the Ticker app

Continue Reading

Leaders

Investing in shares: Insights for fluctuating markets

Jabin Hallihan discusses share investing strategies and market insights from Family Financial Solutions ahead of 2026

Published

on

Jabin Hallihan discusses share investing strategies and market insights from Family Financial Solutions ahead of 2026

In Short:
– Jabin Hallihan advises diversifying portfolios and buying shares during fluctuating markets, emphasising long-term strategies.
– He highlights AI and copper as promising sectors, predicting strong earnings for BHP in 2026.

Jabin Hallihan from Family Financial Solutions shares expert advice on investing in shares as markets fluctuate. He highlights the difficulty of timing the market and echoes Warren Buffett’s philosophy: the best time to buy shares was yesterday. For investors, understanding market timing is crucial.

The ASX 200 is currently valued at around 8,500, slightly below its October peak of 9,000. With a price-to-earnings ratio near 17, above the long-term average of 14, expected earnings for the coming year look promising at 10–11%. Hallihan emphasises the importance of a diversified portfolio and identifies AI as a continuing investment theme, while high-quality stocks like BHP and Rio Tinto offer resilience during downturns.

For funding acquisitions, consider taking profits from outperforming US tech stocks and reallocating into leading Australian resource companies. Looking into 2026, AI investment by major firms is set to accelerate, and the Australian mining sector—particularly copper—could provide significant upside. Jabin Hallihan can be contacted through Family Financial Solutions in Heatherton, Victoria.


Download the Ticker app

Continue Reading

Leaders

Innovative plant-based smoked salmon launching in January

Published

on

Baruch Dach discusses SimpliiGood’s innovative plant-based smoked salmon made from solar-powered spirulina aimed at tackling climate change

In Short:
– Baruch Dach founded SimpliiGood, focusing on sustainable protein from solar-powered, desert-grown spirulina for plant-based smoked salmon.
– The company targets the restaurant industry and will launch its product in Israel, followed by Europe and the US.

SimpliiGood is redefining sustainable protein by turning solar-powered, desert-grown spirulina into whole-cut alternatives like plant-based smoked salmon.

Founder and CTO Baruch Dach explains how spirulina’s unique biology enables it to efficiently convert solar energy into complete protein while maintaining a structure similar to muscle fiber.

Baruch breaks down how the controlled desert environment, powered by renewable energy, allows for scalable, clean, and climate-resilient food production. The conversation dives into how spirulina’s natural properties make it an ideal base for delicate proteins like fish, something many plant-based brands struggle to replicate.

With spirulina at the centre of their innovation, SimpliiGood is pushing the boundaries of clean-label, nutrient-rich protein alternatives.

 SimpliiGood’s smoked salmon is set to launch in January, targeting restaurants, bagels, and sushi markets. Initial sales will be in Israel, expanding to Western Europe, with plans to register with the FDA for a US launch.

The company positions itself as an ingredient supplier in the plant-based and hybrid markets, aiming to provide products that create a satisfying consumer experience, whether they are entirely plant-based or contain small amounts of fish or meat.

For more information, visit SimpliiGood

Ahron Young traveled to Israel as a guest of the Foreign Ministry climate delegation.
Download the Ticker app

Continue Reading

Trending Now